In‐Solution Characterization of Extracellular Vesicles: A New Approach to Evaluating Antibody Binding and Surface Interactions
Journal of Extracellular Vesicles · 2026
DOI: 10.1002/jev2.70269 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2026. Verfasst von Maria-Anthi Kakavoulia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Chemistry, Department of Veterinary Sciences, Ludwig-Maximilians-Universität Munich, München, Germany. Hauptthemen laut MEDLINE: Extracellular Vesicles, Antibodies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Extracellular vesicles (EVs) are emerging as diagnostic and therapeutic agents, yet their nanoscale size limits quantitative single‐vesicle analysis of surface epitopes and molecular interactions. Flow‐Induced Dispersion Analysis (FIDA) is a microfluidic technique enabling real‐time measurement of hydrodynamic size and interaction kinetics using fluorescent ligands without requiring surface immobilization. Here, FIDA was applied to characterize EV–antibody interactions using anti‐CD63 antibodies across three EV sources: EVs from genetically engineered HEK cells expressing CD63‐eGFP or CD63‐NeonGreen‐Fc domain (CD63‐NG‐Fc), and EVs from clonally expanded immortalized mesenchymal stromal cells (ciMSCs). FIDA‐measured EV diameter sizes ranged from 40 to 90 nm, compared to 70–200 nm as determined by Nanoparticle Tracking Analysis (NTA), likely reflecting methodological differences or NTA's sensitivity to non‐EV particles. CD63‐binding EC 50 values were 1.9 × 10 8 particles/mL for CD63‐eGFP EVs and 8.4 × 10 8 to 2.4 × 10 9 particles/mL for ciMSC EVs, indicating higher epitope abundance in engineered vesicles. Within a broader antibody titration, maximal antibody loading to the Fc‐receptor domain on EVs was observed at 0.5–5 nM, reaching 30%–40% for IgG1 and 15%–20% for Cetuximab. These results establish FIDA as a high‐resolution, label‐efficient tool for quantifying EV‐antibody interactions and epitope accessibility, supporting its integration into EV standardization and quality control workflows.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Biochemistry and Chemistry, Department of Veterinary Sciences, Ludwig-Maximilians-Universität Munich, München, Germany.
- School of Life Sciences, University of Applied Sciences, Muttenz, Switzerland.
- Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
- Section of Clinical and Comparative Neuropathology, Institute of Veterinary Pathology, Ludwig-Maximilians-Universität Munich, Munich, Germany.
- Department of Laboratory Medicine, Division of Biomolecular and Cellular Medicine, Karolinska Institutet, Stockholm, Sweden.
- Department of Cellular Therapy and Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital, Huddinge, Sweden.
ORCID-Profile: Tanja J Kutzner, Tobias Tertel, Dominik Meinel, André Görgens, Anna-Kristin Ludwig
Zitieren
APA
Kakavoulia, M. A., Spies, P., Kutzner, T. J., Tertel, T., Franzmeier, S., Andaloussi, S. E., Giebel, B., Kaltner, H., Meinel, D., Görgens, A., & Ludwig, A. K. (2026). In‐Solution Characterization of Extracellular Vesicles: A New Approach to Evaluating Antibody Binding and Surface Interactions. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70269
Vancouver
Kakavoulia MA, Spies P, Kutzner TJ, Tertel T, Franzmeier S, Andaloussi SE, et al. In‐Solution Characterization of Extracellular Vesicles: A New Approach to Evaluating Antibody Binding and Surface Interactions. Journal of Extracellular Vesicles. 2026. doi:10.1002/jev2.70269
BibTeX
@article{Kakavoulia2026,
author = {Kakavoulia, Maria-Anthi and Spies, Peter and Kutzner, Tanja J and Tertel, Tobias and Franzmeier, Sophie and Andaloussi, Samir El and Giebel, Bernd and Kaltner, Herbert and Meinel, Dominik and Görgens, André and Ludwig, Anna-Kristin},
title = {In‐Solution Characterization of Extracellular Vesicles: A New Approach to Evaluating Antibody Binding and Surface Interactions},
journal = {Journal of Extracellular Vesicles},
year = {2026},
doi = {10.1002/jev2.70269}
}
EUVIMED